Last Updated :
19 November 2009 at 01:05 IST
Sun Pharma gets USFDA nod
MUMBAI (Commodity Online): Indian drug maker, Sun Pharmaceutical Industries Ltd (BOM: 524715) on Wednesday announced that the company’s subsidiary has received the formal nod from the US drug regulator.
The group’s subsidiary has received the US Food and Drug Administration (USFDA) approval for anti-hypertension drug.
Pay low, earn more through Commodity Trading TipsThe company has received approval for Nicardipine Hydrocloride injections, available in the strength of 25 mg/10ml, Sun Pharmaceutical said in a filing to the Bombay Stock Exchange (BSE).
The injections are used for short-term treatment of hypertension when oral therapy is not feasible, the filing added. The company stocks have surged by close to 6% during past one month on the BSE.
MCX WHEAT 01 January 2020
contract was trading at
Rs 0 . What's your view on it?
After reading this article, people also read: